The nation of Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) over five years over Washington's demand for confidential data.
This rejection was revealed after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson later clarified that the United States was demanding access to biological samples for scientific study and commercial purposes while refused to share the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued negotiations to find a deal acceptable to both sides so the country's critical HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and accountability.
According to reports, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our citizens if a future health crisis arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending systems previously set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This framework is intended to guarantee that when a nation provides its information, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body said it acknowledged the official position, but recommended that talks must proceed given that a large portion of the country's HIV programmes depended on international support.
"If technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it added.
The situation highlights the ongoing challenges between receiving much-needed international aid and safeguarding a country's data in an increasingly interconnected world.